Cargando…

1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)

The asymmetric unit of the title compound, (C(13)H(15)N(2)S(2))[RuCl(3)(C(10)H(14))], contains a 1,3-(2-thienylmeth­yl)-4,5-dihydro­imidazolium cation and a trichlorido(η (6)-p-cymene)ruthenate(II) anion. The thio­phene rings of the cation are disordered by an 180° rotation about the thio­phene–CH(2...

Descripción completa

Detalles Bibliográficos
Autores principales: Arslan, Hakan, VanDerveer, Don, Özdemir, İsmail, Gürbüz, Nevin, Gök, Yetkin, Çetinkaya, Bekir
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968218/
https://www.ncbi.nlm.nih.gov/pubmed/21581774
http://dx.doi.org/10.1107/S1600536809000464
_version_ 1782189808773234688
author Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Gürbüz, Nevin
Gök, Yetkin
Çetinkaya, Bekir
author_facet Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Gürbüz, Nevin
Gök, Yetkin
Çetinkaya, Bekir
author_sort Arslan, Hakan
collection PubMed
description The asymmetric unit of the title compound, (C(13)H(15)N(2)S(2))[RuCl(3)(C(10)H(14))], contains a 1,3-(2-thienylmeth­yl)-4,5-dihydro­imidazolium cation and a trichlorido(η (6)-p-cymene)ruthenate(II) anion. The thio­phene rings of the cation are disordered by an 180° rotation about the thio­phene–CH(2) bonds with occupancies of 0.847 (5)/0.153 (5) and 0.700 (5)/0.300 (5), respectively. The Ru atom exhibits a distorted octa­hedral coordination with the benzene ring of the p-cymene ligand formally occupying three sites and three Cl atoms occupying the other three sites. The short C—N bond lengths in the imidazoline ring indicate partial electron delocalization within the N—C—N fragment. Cation and anions are connected through five inter­molecular C—H⋯Cl hydrogen bonds and one C—H⋯π hydrogen bond, forming a three-dimensional hydrogen-bonded network.
format Text
id pubmed-2968218
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29682182010-12-30 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II) Arslan, Hakan VanDerveer, Don Özdemir, İsmail Gürbüz, Nevin Gök, Yetkin Çetinkaya, Bekir Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The asymmetric unit of the title compound, (C(13)H(15)N(2)S(2))[RuCl(3)(C(10)H(14))], contains a 1,3-(2-thienylmeth­yl)-4,5-dihydro­imidazolium cation and a trichlorido(η (6)-p-cymene)ruthenate(II) anion. The thio­phene rings of the cation are disordered by an 180° rotation about the thio­phene–CH(2) bonds with occupancies of 0.847 (5)/0.153 (5) and 0.700 (5)/0.300 (5), respectively. The Ru atom exhibits a distorted octa­hedral coordination with the benzene ring of the p-cymene ligand formally occupying three sites and three Cl atoms occupying the other three sites. The short C—N bond lengths in the imidazoline ring indicate partial electron delocalization within the N—C—N fragment. Cation and anions are connected through five inter­molecular C—H⋯Cl hydrogen bonds and one C—H⋯π hydrogen bond, forming a three-dimensional hydrogen-bonded network. International Union of Crystallography 2009-01-10 /pmc/articles/PMC2968218/ /pubmed/21581774 http://dx.doi.org/10.1107/S1600536809000464 Text en © Arslan et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Gürbüz, Nevin
Gök, Yetkin
Çetinkaya, Bekir
1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title_full 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title_fullStr 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title_full_unstemmed 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title_short 1,3-Bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(II)
title_sort 1,3-bis(2-thienylmeth­yl)-4,5-dihydro­imidazolium trichlorido(η(6)-p-cymene)ruthenate(ii)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968218/
https://www.ncbi.nlm.nih.gov/pubmed/21581774
http://dx.doi.org/10.1107/S1600536809000464
work_keys_str_mv AT arslanhakan 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii
AT vanderveerdon 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii
AT ozdemirismail 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii
AT gurbuznevin 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii
AT gokyetkin 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii
AT cetinkayabekir 13bis2thienylmethyl45dihydroimidazoliumtrichloridoē6pcymeneruthenateii